JANUARY 7, 2016 / KEVIN MCCORMACK, CIRM blog Those of us fortunate to have good health take so many things for granted, not the least of which is our ability to see. But, according to the World Health Organization, there are 39 million people worldwide who are blind, and another 246 million who are visually
Wed, 10/21/2015 - 9:38am Cynthia Fox, Science Writer Embryonic stem (ES) cell-like stem cells made from adult cells—and morphed into eye cells—are not rejected by the immune system, according to “humanized mouse” data in Cell Stem Cell. Coming alongside news that the first UK macular degeneration patient received eye cells made from normal ES cells,
A patient receives the first human eye cell transplant developed by a UCSB neuroscientist who founded the London Project to Cure Blindness By Julie Cohen Monday, September 28, 2015 - Santa Barbara, CA A clinical trial using stem cell-derived ocular cells for the treatment of wet age-related macular degeneration (AMD) has been initiated in England. This was
Sep 1, 2015 A $32 million public-private bank — where California researchers collect stem cells and scientists from around the world can make withdrawals — officially opened Tuesday with the aim of accelerating the use of engineered stem cells to tackle a wide range of diseases. The bank, funded by the California Institute for Regenerative
Visual cortex of blind children can be remodeled to process language. Anne Trafton | MIT News Office August 27, 2015 In 2011, MIT neuroscientist Rebecca Saxe and colleagues reported that in blind adults, brain regions normally dedicated to vision processing instead participate in language tasks such as speech and comprehension. Now, in a study of
Amy Millen, associate professor of epidemiology and environmental health in the University at Buffalo's School of Public Health and Health Professions, is lead author on a paper published Aug. 27 in JAMA Ophthalmology. UB research shows women with two risk alleles and low D status are more likely to have the disease By David J.
NIH scientists propose novel mechanism to explain autoimmune uveitis August 18, 2015 - NIH - The inflammatory eye disorder autoimmune uveitis occurs when a person’s immune system goes awry, attacking proteins in the eye. What spurs this response is a mystery, but now a study on mice suggests that bacteria in the gut may provide
Funding from Bill & Melinda Gates Foundation enables research to resume in Liberia as Ebola epidemic wanes August 13, 2015 By Caroline Arbanas ISSOUF SANOGO/AGENCE FRANCE-PRESSE Funding from the Bill & Melinda Gates Foundation is aiding efforts by Washington University researchers to eliminate river blindness and elephantiasis, parasitic worm diseases common in parts of Africa
OHSU scientists unlock first critical step toward gene therapy treatment for patients with mitochondrial disease
07/15/15 Portland, Ore. Gene-based cures for human diseases are now on the horizon A study led by Shoukhrat Mitalipov, Ph.D., and Hong Ma, M.D., Ph.D., at the Center for Embryonic Cell and Gene Therapy at Oregon Health & Science University and the Oregon National Primate Research Center has revealed the first critical step in developing novel
Thursday, July 2, 2015 NIH research points to microglia as potential therapeutic target in retinitis pigmentosa Spider-like cells inside the brain, spinal cord and eye hunt for invaders, capturing and then devouring them. These cells, called microglia, often play a beneficial role by helping to clear trash and protect the central nervous system against infection.